ZMAT2
gene geneOn this page
Also known as FLJ31121hSNU23Snu23
Summary
ZMAT2 (zinc finger matrin-type 2, HGNC:26433) is a protein-coding gene on chromosome 5q31.3, encoding Zinc finger matrin-type protein 2 (Q96NC0). Involved in pre-mRNA splicing as a component of the spliceosome. It is a common-essential gene (DepMap: required in 99.9% of cancer cell lines).
Predicted to enable DNA binding activity and zinc ion binding activity. Involved in mRNA splicing, via spliceosome. Located in nucleus. Part of U2-type precatalytic spliceosome.
Source: NCBI Gene 153527 — RefSeq curated summary.
At a glance
- Gene–disease (curated): congenital radioulnar synostosis (Limited, GenCC)
- GWAS associations: 6
- Clinical variants (ClinVar): 17 total
- Cancer dependency (DepMap): dependent in 99.9% of screened cell lines (common-essential)
- MANE Select transcript:
NM_144723
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26433 |
| Approved symbol | ZMAT2 |
| Name | zinc finger matrin-type 2 |
| Location | 5q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ31121, hSNU23, Snu23 |
| Ensembl gene | ENSG00000146007 |
| Ensembl biotype | protein_coding |
| OMIM | 619930 |
| Entrez | 153527 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay
ENST00000274712, ENST00000506644, ENST00000519913, ENST00000924923, ENST00000924924
RefSeq mRNA: 1 — MANE Select: NM_144723
NM_144723
CCDS: CCDS4239
Canonical transcript exons
ENST00000274712 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001085718 | 140705613 | 140706686 |
| ENSE00001127540 | 140700447 | 140700478 |
| ENSE00003299003 | 140703918 | 140703991 |
| ENSE00003463244 | 140700819 | 140700912 |
| ENSE00003542009 | 140704426 | 140704571 |
| ENSE00003569063 | 140702006 | 140702129 |
Expression profiles
Bgee: expression breadth ubiquitous, 261 present calls, max score 98.39.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 65.8752 / max 2181.7494, expressed in 1825 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 58933 | 65.8752 | 1825 |
Top tissues by expression
261 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 98.39 | gold quality |
| monocyte | CL:0000576 | 97.98 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.95 | gold quality |
| embryo | UBERON:0000922 | 97.92 | gold quality |
| ganglionic eminence | UBERON:0004023 | 97.92 | gold quality |
| leukocyte | CL:0000738 | 97.91 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.86 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.47 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.45 | gold quality |
| putamen | UBERON:0001874 | 97.34 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.33 | gold quality |
| colonic epithelium | UBERON:0000397 | 97.16 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.05 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.01 | gold quality |
| ileal mucosa | UBERON:0000331 | 96.94 | gold quality |
| muscle of leg | UBERON:0001383 | 96.93 | gold quality |
| frontal cortex | UBERON:0001870 | 96.84 | gold quality |
| right frontal lobe | UBERON:0002810 | 96.84 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 96.79 | gold quality |
| neocortex | UBERON:0001950 | 96.77 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 96.72 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 96.67 | gold quality |
| tibialis anterior | UBERON:0001385 | 96.64 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.55 | gold quality |
| amygdala | UBERON:0001876 | 96.46 | gold quality |
| granulocyte | CL:0000094 | 96.43 | gold quality |
| rectum | UBERON:0001052 | 96.38 | gold quality |
| ventricular zone | UBERON:0003053 | 96.37 | gold quality |
| esophagus mucosa | UBERON:0002469 | 96.28 | gold quality |
| thoracic aorta | UBERON:0001515 | 96.25 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
85 targeting ZMAT2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 99.9% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 1)
- Zmat2 in mammals: conservation and diversification among genes and Pseudogenes. (PMID:32005145)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zmat2 | ENSDARG00000004956 |
| mus_musculus | Zmat2 | ENSMUSG00000001383 |
| rattus_norvegicus | Zmat2 | ENSRNOG00000072190 |
| drosophila_melanogaster | CG11586 | FBGN0035520 |
Paralogs (9): ZNF346 (ENSG00000113761), ZNF385B (ENSG00000144331), ZNF385D (ENSG00000151789), ZNF385A (ENSG00000161642), ZMAT4 (ENSG00000165061), ZMAT1 (ENSG00000166432), KRCC1 (ENSG00000172086), ZMAT3 (ENSG00000172667), ZNF385C (ENSG00000187595)
Protein
Protein identifiers
Zinc finger matrin-type protein 2 — Q96NC0 (reviewed: Q96NC0)
All UniProt accessions (3): Q96NC0, R4GMX9, R4GNG8
UniProt curated annotations — full annotation on UniProt →
Function. Involved in pre-mRNA splicing as a component of the spliceosome.
Subunit / interactions. Component of the spliceosome B complex.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_653324* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003604 | Matrin/U1-like-C_Znf_C2H2 | Domain |
| IPR022755 | Znf_C2H2_jaz | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR040107 | Snu23 | Family |
Pfam: PF12171
UniProt features (24 total): cross-link 10, helix 3, turn 2, strand 2, region of interest 2, initiator methionine 1, chain 1, zinc finger region 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
13 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8H6K | ELECTRON MICROSCOPY | 2.7 |
| 8Q7N | ELECTRON MICROSCOPY | 3.1 |
| 8QPE | ELECTRON MICROSCOPY | 3.1 |
| 9R3D | ELECTRON MICROSCOPY | 3.12 |
| 6AHD | ELECTRON MICROSCOPY | 3.8 |
| 7ABF | ELECTRON MICROSCOPY | 3.9 |
| 8QZS | ELECTRON MICROSCOPY | 4.1 |
| 7AAV | ELECTRON MICROSCOPY | 4.2 |
| 5O9Z | ELECTRON MICROSCOPY | 4.5 |
| 8QO9 | ELECTRON MICROSCOPY | 5.29 |
| 7ABG | ELECTRON MICROSCOPY | 7.8 |
| 7ABI | ELECTRON MICROSCOPY | 8 |
| 9R8V | ELECTRON MICROSCOPY | 8.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NC0-F1 | 72.37 | 0.03 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (11): 45, 55, 61, 64, 70, 102, 123, 2, 8, 36, 39
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-72163 | mRNA Splicing - Major Pathway |
MSigDB gene sets: 126 (showing top):
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA, IRF1_Q6, GOBP_RNA_SPLICING, REACTOME_MRNA_SPLICING, REACTOME_METABOLISM_OF_RNA, GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX, GOCC_PRECATALYTIC_SPLICEOSOME, chr5q31, GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX, GOCC_SPLICEOSOMAL_COMPLEX, GOCC_RIBONUCLEOPROTEIN_COMPLEX, TARTE_PLASMA_CELL_VS_PLASMABLAST_DN, KEGG_SPLICEOSOME
GO Biological Process (3): mRNA splicing, via spliceosome (GO:0000398), mRNA processing (GO:0006397), RNA splicing (GO:0008380)
GO Molecular Function (5): DNA binding (GO:0003677), zinc ion binding (GO:0008270), nucleic acid binding (GO:0003676), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (5): nucleus (GO:0005634), nucleoplasm (GO:0005654), U4/U6 x U5 tri-snRNP complex (GO:0046540), U2-type precatalytic spliceosome (GO:0071005), spliceosomal complex (GO:0005681)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| mRNA Splicing | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA processing | 2 |
| binding | 2 |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1 |
| mRNA processing | 1 |
| mRNA metabolic process | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| U5 snRNP | 1 |
| U4/U6 snRNP | 1 |
| spliceosomal tri-snRNP complex | 1 |
| U2-type spliceosomal complex | 1 |
| U1 snRNP | 1 |
| U2 snRNP | 1 |
| U4/U6 x U5 tri-snRNP complex | 1 |
| precatalytic spliceosome | 1 |
| nuclear protein-containing complex | 1 |
| ribonucleoprotein complex | 1 |
Protein interactions and networks
STRING
1290 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZMAT2 | MFAP1 | P55081 | 905 |
| ZMAT2 | PRPF38A | Q8NAV1 | 827 |
| ZMAT2 | SMU1 | Q2TAY7 | 826 |
| ZMAT2 | SART1 | O43290 | 783 |
| ZMAT2 | WBP4 | O75554 | 777 |
| ZMAT2 | SNRNP200 | O75643 | 626 |
| ZMAT2 | DDX23 | Q9BUQ8 | 604 |
| ZMAT2 | PRPF6 | O94906 | 594 |
| ZMAT2 | PRPF31 | Q8WWY3 | 578 |
| ZMAT2 | PRP4K | Q13523 | 535 |
| ZMAT2 | SF3A3 | Q12874 | 531 |
| ZMAT2 | TXNL4A | P83876 | 530 |
| ZMAT2 | RBM42 | Q9BTD8 | 523 |
| ZMAT2 | SF3A2 | Q15428 | 517 |
| ZMAT2 | PPIH | O43447 | 502 |
IntAct
222 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED4 | MED19 | psi-mi:“MI:0914”(association) | 0.900 |
| FXR2 | ZMAT2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GOLGA2 | ZMAT2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRAF2 | ZMAT2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZMAT2 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZMAT2 | TRAF2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| HTT | ZMAT2 | psi-mi:“MI:0915”(physical association) | 0.700 |
BioGRID (133): ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid), ZMAT2 (Two-hybrid)
ESM2 similar proteins: A1C8E1, A3LU29, B0JZ89, B2W2Y7, O43082, O45766, O94389, O95926, P0CM66, P0CM67, P53188, Q0C7E6, Q0UVD1, Q0V389, Q1E554, Q28HN4, Q28IN9, Q28XK6, Q2HDR6, Q2TVY9, Q3B748, Q4I5Z5, Q568A0, Q59WI7, Q5B020, Q68EY7, Q6BIC4, Q6BWR0, Q6C1V5, Q6CNQ3, Q6DD17, Q6DGP2, Q6DKE6, Q6FVC7, Q6NVR5, Q6PHE8, Q752U2, Q7SDA6, Q7ZY35, Q8AVQ6
Diamond homologs: P34670, Q96NC0, Q9CPW7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
556 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:140700474:GCGGG:G | donor_gain | 1.0000 |
| 5:140700814:CACAG:C | acceptor_loss | 1.0000 |
| 5:140700815:ACAG:A | acceptor_loss | 1.0000 |
| 5:140700816:CAGAC:C | acceptor_loss | 1.0000 |
| 5:140700817:A:AG | acceptor_gain | 1.0000 |
| 5:140700817:AGA:A | acceptor_loss | 1.0000 |
| 5:140700818:G:GA | acceptor_gain | 1.0000 |
| 5:140700818:GA:G | acceptor_gain | 1.0000 |
| 5:140700818:GACA:G | acceptor_gain | 1.0000 |
| 5:140700818:GACAA:G | acceptor_gain | 1.0000 |
| 5:140700891:G:GT | donor_gain | 1.0000 |
| 5:140700909:GATG:G | donor_gain | 1.0000 |
| 5:140700913:GTG:G | donor_loss | 1.0000 |
| 5:140700914:T:A | donor_loss | 1.0000 |
| 5:140701994:ATTAT:A | acceptor_gain | 1.0000 |
| 5:140701997:A:AG | acceptor_gain | 1.0000 |
| 5:140701997:AT:A | acceptor_gain | 1.0000 |
| 5:140701998:T:G | acceptor_gain | 1.0000 |
| 5:140701998:T:TA | acceptor_gain | 1.0000 |
| 5:140702001:TTCAG:T | acceptor_loss | 1.0000 |
| 5:140702002:TCAG:T | acceptor_loss | 1.0000 |
| 5:140702003:CAGG:C | acceptor_loss | 1.0000 |
| 5:140702004:A:AG | acceptor_gain | 1.0000 |
| 5:140702004:AG:A | acceptor_gain | 1.0000 |
| 5:140702005:G:GT | acceptor_gain | 1.0000 |
| 5:140702005:GG:G | acceptor_gain | 1.0000 |
| 5:140702005:GGA:G | acceptor_gain | 1.0000 |
| 5:140702005:GGAA:G | acceptor_gain | 1.0000 |
| 5:140702005:GGAAA:G | acceptor_gain | 1.0000 |
| 5:140702082:G:GT | donor_gain | 1.0000 |
AlphaMissense
1341 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:140700846:T:A | W16R | 1.000 |
| 5:140700846:T:C | W16R | 1.000 |
| 5:140700848:G:C | W16C | 1.000 |
| 5:140700848:G:T | W16C | 1.000 |
| 5:140702039:T:C | L49S | 1.000 |
| 5:140702047:A:G | R52G | 1.000 |
| 5:140702048:G:C | R52T | 1.000 |
| 5:140702048:G:T | R52M | 1.000 |
| 5:140702049:G:C | R52S | 1.000 |
| 5:140702049:G:T | R52S | 1.000 |
| 5:140702066:T:C | L58S | 1.000 |
| 5:140702081:G:A | G63E | 1.000 |
| 5:140702081:G:T | G63V | 1.000 |
| 5:140702093:T:A | V67D | 1.000 |
| 5:140702096:T:A | I68N | 1.000 |
| 5:140702096:T:G | I68S | 1.000 |
| 5:140702125:G:A | G78R | 1.000 |
| 5:140702125:G:C | G78R | 1.000 |
| 5:140702126:G:A | G78E | 1.000 |
| 5:140702128:G:A | G79R | 1.000 |
| 5:140702128:G:C | G79R | 1.000 |
| 5:140702129:G:A | G79E | 1.000 |
| 5:140702129:G:T | G79V | 1.000 |
| 5:140703925:T:A | C82S | 1.000 |
| 5:140703925:T:C | C82R | 1.000 |
| 5:140703925:T:G | C82G | 1.000 |
| 5:140703926:G:A | C82Y | 1.000 |
| 5:140703926:G:C | C82S | 1.000 |
| 5:140703926:G:T | C82F | 1.000 |
| 5:140703927:C:G | C82W | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000368237 (5:140705272 C>A), RS1000440110 (5:140704886 A>G), RS1000909244 (5:140701953 T>A,G), RS1000984694 (5:140699872 T>C), RS1001353598 (5:140700190 G>A,T), RS1002329302 (5:140706243 G>A,C), RS1002387717 (5:140698926 C>A,T), RS1002481235 (5:140699446 A>G), RS1003213047 (5:140704145 A>G), RS1003256461 (5:140704720 G>A,C), RS1003328189 (5:140703685 ACT>A), RS1003736420 (5:140704183 T>A), RS1004805818 (5:140701779 T>C), RS1005111137 (5:140701342 G>A), RS1005501067 (5:140700710 C>G,T)
Disease associations
OMIM: gene MIM:619930 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| congenital radioulnar synostosis | Limited | Autosomal dominant |
Mondo (1): congenital radioulnar synostosis (MONDO:0017985)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004946_157 | Schizophrenia | 2.000000e-08 |
| GCST006041_22 | Major depressive disorder | 9.000000e-08 |
| GCST006624_37 | Systolic blood pressure | 8.000000e-15 |
| GCST006803_54 | Schizophrenia | 8.000000e-07 |
| GCST010002_39 | Refractive error | 2.000000e-14 |
| GCST010146_22 | Serum immune biomarker levels | 7.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
| EFO:0004872 | inflammatory biomarker measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C562408 | Radioulnar Synostosis (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| alpha-pinene | affects cotreatment, increases oxidation, increases abundance | 1 |
| bisphenol A | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| mono-(2-ethylhexyl)phthalate | increases expression | 1 |
| methacrylaldehyde | increases abundance, affects cotreatment, increases oxidation | 1 |
| yessotoxin | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| PP242 | increases expression | 1 |
| Norethindrone Acetate | affects cotreatment, increases expression | 1 |
| Acrolein | affects cotreatment, increases oxidation, increases abundance | 1 |
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Ozone | affects cotreatment, increases oxidation, increases abundance | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Volatile Organic Compounds | affects cotreatment, increases oxidation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: congenital radioulnar synostosis
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital radioulnar synostosis